(Q48125310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

Gaurav D Shah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Joel S Silver

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Steven S Rosenfeld

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Andrew B Lassman

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

27 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

217-222

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17594055%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-007-9408-1

1 January 2020

exact match

0 references

cites work

How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9408-1

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

21 January 2018

1 reference

12 December 2020

Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph-negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI-571 therapy

1 reference

12 December 2020

Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease

1 reference

12 December 2020

Radiation resistance and stem-like cells in brain tumors.

1 reference

12 December 2020

Severe bone marrow aplasia following imatinib mesylate in a patient with chronic myelogenous leukemia

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

1 reference

12 December 2020

Temozolomide in the treatment of recurrent malignant glioma

1 reference

12 December 2020

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

12 December 2020

The place of hydroxyurea in the treatment of primary brain tumors

1 reference

12 December 2020

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

12 December 2020

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

12 December 2020

Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme

1 reference

12 December 2020

Imatinib and hydroxyurea in pretreated progressive glioblastoma multiforme: a patient series

1 reference

12 December 2020

Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020